Concepedia

Reducing infection risk in multiple sclerosis and neuromyelitis optica spectrum disorders: a Brazilian reference center's approach

Ana Beatriz Ayroza Galvão Ribeiro Gomes, Lucas Bueno Feo, Guilherme Diogo Silva, Caio César Diniz Disserol, Renata Barbosa Paolilo, Amanda Nazareth Lara, Adriana Coracini Tonácio, María Fernanda Mendes, Samira Luisa Pereira Apóstolos, Dagoberto Callegaro

Arquivos de Neuro-Psiquiatria · 2022 · 10 citations · 29 references

DOIFull text

Open access

Abstract

We propose a vaccination schedule, infectious screening routine, and prophylactic measures based on the current scientific evidence. Awareness of emergent tropical diseases is necessary due to evidence of demyelinating events and possible parainfectious cases of MS and NMOSD.

References

29

Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy for Crohn's Disease

Gert Van Assche, Marc Van Ranst, Raf Sciot et al. · New England Journal of Medicine · 2005 · 1.1K citations · Full text

, , +15

Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies

Gustavo Luna, Peter Alping, Joachim Burman et al. · JAMA Neurology · 2019 · 492 citations · Full text

Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis

Amit Bar‐Or, Jonathan Calkwood, Cathy Chognot et al. · Neurology · 2020 · 332 citations · Full text

Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia

Sara Barmettler, Mei‐Sing Ong, Jocelyn R. Farmer et al. · JAMA Network Open · 2018 · 325 citations · Full text

Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studies

Pei‐Ran Ho, Harold Koendgen, Nolan Campbell et al. · The Lancet Neurology · 2017 · 310 citations

, , +12